Research.Patient.info
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER research hub
2 indexed studies · 0 currently recruiting
- authorisedTherapeutic confirmatory (Phase III)
AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
This study looks at a new drug, PF-08634404, combined with chemotherapy for advanced lung cancer. It compares this combination to another treatment, pembrolizumab with chemotherapy, to see which works best and is safest for adults.
France · Italy · Hungary - active not recruitingPHASE3
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
This study looks at a new drug, trastuzumab deruxtecan, for people with a certain type of advanced lung cancer. It compares this new drug to standard treatments to see if it works better and is safe.
United States · Austria · Belgium